Landiolol
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration |
IV |
ATC code | C07AB14 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
|
|
CAS Number | 133242-30-5 |
PubChem (CID) | 114905 |
ChemSpider | 102855 |
UNII | 62NWQ924LH |
KEGG | D01847 |
Chemical and physical data | |
Formula | C25H39N3O8 |
Molar mass | 509.59 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(what is this?) (verify) |
Landiolol (INN) is a drug which acts as a highly cardioselective, ultra short-acting beta blocker. It is used as an antiarrhythmic agent.
References[edit]
- Yoshiya I (December 1998). "[Landiolol hydrochloride, a new sympathetic beta blocker]". Masui (in Japanese). 47 Suppl: S126–32. PMID 9921175.
- Ogata J, Okamoto T, Minami K (2003). "Landiolol for the treatment of tachyarrhythmia associated with atrial fibrillation". Can J Anaesth. 50 (7): 753. doi:10.1007/BF03018726. PMID 12944459.
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |